| Produkt-Name |
beta-Nicotinamide adenine dinucleotide |
| Englischer Name |
beta-Nicotinamide adenine dinucleotide; nadide; beta-Diphosphopyridine nucleotide; cozymase; beta-dpn; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] phosphate; NAD; beta-Nicotinamide adenine dinucleotide trihydrate; β-Nicotinamide Adenine Dinuclotide; β-Nicotinamide adenine dinucleotide; NAD+ |
| Molekulare Formel |
C21H26N7O14P2 |
| Molecular Weight |
662.4177 |
| InChI |
InChI=1/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p-1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 |
| CAS Registry Number |
53-84-9 |
| EINECS |
200-184-4 |
| Molecular Structure |
|
| Gefahrensymbole |
|
| Risk Codes |
|
| Safety Beschreibung |
S24/25:Avoid contact with skin and eyes.;
|
|
